This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Resumen de acción NVCN
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Competidores de Neovasc Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | CA$40.15 |
| 52 Week High | CA$41.20 |
| 52 Week Low | CA$6.00 |
| Beta | 1.98 |
| 1 Month Change | 0.35% |
| 3 Month Change | 39.90% |
| 1 Year Change | 224.44% |
| 3 Year Change | -56.12% |
| 5 Year Change | -97.32% |
| Change since IPO | -99.98% |
Noticias y actualizaciones recientes
Rentabilidad de los accionistas
| NVCN | CA Medical Equipment | Mercado CA | |
|---|---|---|---|
| 7D | 0.6% | 2.3% | 0.7% |
| 1Y | 224.4% | -26.5% | 4.9% |
Rentabilidad vs. Industria: NVCN exceeded the Canadian Medical Equipment industry which returned -20.8% over the past year.
Rentabilidad vs. Mercado: NVCN exceeded the Canadian Market which returned -8.9% over the past year.
Volatilidad de los precios
| NVCN volatility | |
|---|---|
| NVCN Average Weekly Movement | 10.5% |
| Medical Equipment Industry Average Movement | 11.4% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in CA Market | 18.1% |
| 10% least volatile stocks in CA Market | 3.0% |
Precio estable de las acciones: NVCN's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: NVCN's weekly volatility (10%) has been stable over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2000 | 60 | Fred Colen | neovasc.com |
Resumen de fundamentos de Neovasc Inc.
| Estadísticas fundamentales de NVCN | |
|---|---|
| Capitalización bursátil | CA$110.78m |
| Beneficios(TTM) | -CA$55.39m |
| Ingresos (TTM) | CA$5.11m |
21.7x
Ratio precio-ventas (PS)-2.0x
Ratio precio-beneficio (PE)¿Está NVCN sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de NVCN | |
|---|---|
| Ingresos | US$3.81m |
| Coste de los ingresos | US$5.07m |
| Beneficio bruto | -US$1.27m |
| Otros gastos | US$39.93m |
| Beneficios | -US$41.20m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -14.93 |
| Margen bruto | -33.37% |
| Margen de beneficio neto | -1,082.90% |
| Ratio deuda/patrimonio | 79.8% |
¿Cómo se ha desempeñado NVCN a largo plazo?
Ver rendimiento histórico y comparativa